These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 21670092

  • 1. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
    Davidson DF, Hammond PJ, Murphy D, Carachi R.
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
    [Abstract] [Full Text] [Related]

  • 2. Reference intervals for urinary catecholamines and metabolites from birth to adulthood.
    Pussard E, Neveux M, Guigueno N.
    Clin Biochem; 2009 Apr; 42(6):536-9. PubMed ID: 19027729
    [Abstract] [Full Text] [Related]

  • 3. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y, Desager JP, Harvengt C.
    Bull Cancer; 1990 Apr; 77(10):985-9. PubMed ID: 2249018
    [Abstract] [Full Text] [Related]

  • 4. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
    Tuchman M, Stoeckeler JS.
    Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
    Strenger V, Kerbl R, Dornbusch HJ, Ladenstein R, Ambros PF, Ambros IM, Urban C.
    Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
    [Abstract] [Full Text] [Related]

  • 6. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
    Candito M, Thyss A, Albertini M, Deville A, Politano S, Mariani R, Chambon P.
    Med Pediatr Oncol; 1992 May; 20(3):215-20. PubMed ID: 1574031
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
    Davidson DF, Grosset K, Grosset D.
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
    [Abstract] [Full Text] [Related]

  • 13. Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.
    Lam L, Woollard GA, Teague L, Davidson JS.
    Ann Clin Biochem; 2017 Mar; 54(2):264-272. PubMed ID: 27235704
    [Abstract] [Full Text] [Related]

  • 14. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
    Tran MT, Baglin J, Tran TT, Hoang KT, Phung LT, Read A, Greaves RF.
    Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
    [Abstract] [Full Text] [Related]

  • 15. Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines.
    Davidson FD.
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):316-20. PubMed ID: 15298744
    [Abstract] [Full Text] [Related]

  • 16. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
    Candito M, Soler C, Deville A, Bekri S, Chambon P, Thyss A.
    Med Pediatr Oncol; 1996 Jan; 26(1):57-60. PubMed ID: 7494513
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M, Ramnaraine ML, Woods WG, Krivit W.
    Pediatrics; 1987 Feb; 79(2):203-5. PubMed ID: 3808793
    [Abstract] [Full Text] [Related]

  • 19. Elevation of urinary catecholamines and their metabolites following tyrosine administration in humans.
    Alonso R, Gibson CJ, Wurtman RJ, Agharanya JC, Prieto L.
    Biol Psychiatry; 1982 Jul; 17(7):781-90. PubMed ID: 7115832
    [Abstract] [Full Text] [Related]

  • 20. Urinary VMA, dopamine and the likelihood of neuroblastoma: a preferred way of reporting laboratory results?
    Sies CW, Florkowski CM, Sullivan M, Mackay R, George PM.
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):300-5. PubMed ID: 16824281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.